Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy

Archives of Neurology

Volumn 62, Issue 9, 2005, Pages 1453-1457

  Tuite, Paul J ^a,b   Clark, H Brent ^a,b   Bergeron, Catherine ^c   Bower, Matthew ^a   St George Hyslop, Peter ^c   Mateva, Vesselina ^a   Anderson, John ^a   Knopman, David S ^d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONSANGUINITY; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; EYE MOVEMENT CONTROL; FEMALE; FUNCTIONAL ASSESSMENT; GENE MUTATION; GENETIC HETEROGENEITY; HAPLOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SIBLING; TAUOPATHY; UNITED STATES;

EID: 25144500987     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.62.9.1453     Document Type: Article

References (21)

1. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47:1-9.
2. Brown J, Lantos P, Stratton M, Roques P, Rossor M. Familial progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. 1993;56:473-476.
3. de Yebenes JG, Sarasa JL, Daniel SE, Lees AJ. Familial progressive supranuclear palsy: description of a pedigree and review of the literature. Brain. 1995;118:1095-1103.
4. Gallien P, Verin M, Rancurel G, De Marco O, Eden G. First familial cases of corticobasal degeneration [abstract]. Neurology. 1998;50(suppl 4):A428.
5. Rojo A, Pernaute RS, Fontan A, et al. Clinical genetics of familial progressive supranuclear palsy. Brain. 1999;122:1233-1245.
6. Hattori M, Hashizume Y, Yoshida M, et al. Distribution of astrocytic plaques in the corticobasal degeneration brain and comparison with tuft-shaped astrocytes in the progressive supranuclear palsy brain. Acta Neuropathol (Berl). 2003;106:143-149.
7. Jellinger KA. The neuropathologic diagnosis of secondary parkinsonian syndromes. Adv Neurol. 1996;69:293-303.
8. Pastor P, Pastor E, Carnero C, et al. Familial atypical progressive supranuclear palsy associated with homozigosity for the delN296 mutation in the tau gene. Ann Neurol. 2001;49:263-267.
9. Poorkaj P, Muma NA, Zhukareva V, et al. An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype. Ann Neurol. 2002;52:511-516.
10. Conrad C, Andreadis A, Trojanowski JQ, et al. Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol. 1997;41:277-281.
11. Baker M, Litvan I, Houlden H, et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet. 1999;8:711-715.
12. Houlden H, Baker M, Morris HR, et al. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology. 2001;56:1702-1706.
13. Arai T, Ikeda K, Akiyama H, et al. Different immunoreactivities of the microtubulebinding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol (Berl). 2003;105:489-498.
14. Nasher L. Computerized dynamic posturography. In: Jacobson G, Newman C, Kartush J, eds. Handbook of Balance Function Testing. Chicago, Ill: Mosby-Year Book; 1993:280-307.
15. Jendroska K, Rossor MN, Mathias CJ, Daniel SE. Morphological overlap between corticobasal degeneration and Pick's disease: a clinicopathological report. Mov Disord. 1995;10:111-114.
16. Robinson DA. A method of measuring eye movement using a scleral search coil in a magnetic field. IEEE Trans Biomed Eng. 1963;10:137-145.
17. Wright D, Manos M. PCR Protocol. San Diego, Calif: Academic Press; 1990.
18. Boeve BF, Lang AE, Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol. 2003;54(suppl 5):S15-S19.
19. Dickson DW, Bergeron C, Chin SS, et al. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol. 2002;61:935-946.
20. Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol. 1996;55:97-105.
21. Farrer M, Chan P, Chen R, et al. Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol. 2001;50:293-300.